Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 451 - 500 out of 13,177

Document Document Title
WO/2015/012110A1
 The purpose of the present invention is to provide a technique for manufacturing a C-glycoside derivative with high efficiency and in commercially advantageous conditions. A C-glycoside derivatives can be manufactured in a short perio...  
WO/2015/011441A1
The invention provides methods and materials for use in the detection of influenza viruses which utilise a nanoparticle, for example gold nanoparticule, probe comprising a plurality of glycoconjugate ligands, each glyconjugate ligand (GL...  
WO/2015/008007A1
The invention relates to novel solanidine-derived compounds, the synthesis method thereof and the uses of same in the fields of phytosanitary protection and health. In particular, the invention relates to novel compounds having toxic and...  
WO/2015/006763A1
Sweetened compositions comprising at least one sweetener and rebaudioside X are provided herein. Rebaudioside X is present in the sweetened compositions in a concentration at or below the sweetness recognition threshold, while the at lea...  
WO/2015/004041A1
The present invention relates to the total synthesis of saccharide structures contained in the capsular polysaccharide of Streptococcus pneumoniae type 1, to glycoconjugates containing said saccharide structures obtained by total synthes...  
WO/2012/132022A9
Provided is a compound represented by the formula (I): wherein R1 represents R5=N- (R5 represents a saccharide residue) or (R4 represents a mono- or polyethylene glycol residue); each of R2 and R3, whether identical or not, represents a ...  
WO/2015/006764A1
Rebaudioside M compositions with improved aqueous solubility and methods for preparing the same are provided herein. The rebaudioside M compositions include (i) disordered crystalline compositions comprising rebaudioside M and rebaudiosi...  
WO/2015/000132A1
The present invention provides a method for preparing epirubicin and an intermediate thereof related to the method. The preparation method may comprise: reacting tert-Butyldimethylsilyl chloride with N-trifluoroacetyl adriamycin to obtai...  
WO/2015/000792A1
The current invention is directed towards mixtures of compounds, comprising (A) in the range of from 93 to 97 % by weight compound of general formula (I) (B) in the range of from 3 to 6.5 % by weight compound of general formula (II) (C) ...  
WO/2014/206299A1
Disclosed in the present invention is a method for preparing a liflozin drug intermediate using a microreactor, comprising: mixing compound III dissolved in an organic solvent with an organometallic reagent in a microreactor unit (L) by ...  
WO/2014/146135A3
The present invention relates generally to steviol glycosides, as well as compositions comprising such steviol glycosides. The present invention further extends to methods of preparing and purifying such steviol glycosides and methods fo...  
WO/2014/203887A1
In the present invention, by applying a solution containing the fullerene represented by formula (1) to a substrate and firing at 450°C or higher, an n-type organic semiconductor thin film that has favorable ionization potential and has...  
WO/2014/204866A1
The present disclosure provides mixtures of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both capable of modulating joint inflammation, joint pain, joint stiffness, cartilage degradation, or improving mobilit...  
WO/2014/115174A3
A process for synthesis of enatiomerically pure or enatiomerically enriched or racemic mixture of (+and/or-) epicatechin and its intermediates, comprising the steps of: (i) obtaining penta-protected quercetin; (ii) reducing the penta-pro...  
WO/2014/107652A3
The present invention provides vaccines comprising carbohydrate antigen conjugated to a diphtheria toxin (DT) as a carrier protein, wherein the ratio of the number of carbohydrate antigen molecule to the carrier protein molecule is highe...  
WO/2014/200363A1
The invention relates to sphingoglycolipid analogues which are useful in treating or preventing diseases and conditions such as those relating to infection, atopic disorders, autoimmune diseases or cancer.  
WO/2014/200964A1
The invention relates to processes for preparing (S,S)-secoisolariciresinol diglucoside and (R,R)-secoisolariciresinol diglucoside and compositions comprising the same.  
WO/2014/173957A3
A compound of formula (I) wherein R is a C9-23 polyunsaturated alkenyl group; X is SO3R3, SO2R3, PO3R3, PO2R3, COCHal3, or COOR3; R1 and R2 are each independently H, a C1-6 a iky I group optionally substituted with OH, C6-10 aryl group o...  
WO/2014/196887A1
Derived for the first time are individual (without the addition of penta- and hexa-acyl derivatives) di-, tri- and tetra-acyl S-LPS of endotoxic bacteria and combinations thereof, and the immunobiological, physicochemical and chemical...  
WO/2014/195828A1
The present invention relates to a novel method for synthesising, without a solvent, N-alkyl-glycosyl(di)amine derivatives represented by the following general formula (I): The invention also concerns the use of N-alkyl-glycosyl(di)amine...  
WO/2014/196861A1
A fructoside-containing product is manufactured from a glucose-rich feedstock, in a process wherein glucose to fructose is isomerized by contacting the glucose-rich feedstock with a basic isomerization catalyst in an alcoholic medium at ...  
WO/2014/193856A1
A method for the development of a library of modified sophorolipids using a wide- range of chemical and enzyme catalyst tools to identify modified sophorolipids that can be used in pure form, as mixtures with other modified sophorolipids...  
WO/2014/193183A1
The present invention relates to a method for preparing a sialic acid derivative, wherein the method is characterized in that a process of using N-acetyl-D-glucosamine to prepare CMP-M-acetylneuraminic acid and a process of combining sia...  
WO/2014/192848A1
 It was discovered that an arbekacin derivative containing arbekacin carbonate and a carbamate of arbekacin can be produced by adding carbon dioxide or the like to a solution containing arbekacin free base. It was also discovered that ...  
WO/2014/190024A1
The invention concerns compounds of the formula (I) wherein: Y1 and Y2 are independently a monosaccharide or disaccharide; X1 and X2 are independently -(R9-O)m-, -(R10)P-, -O-(R11-O)q-, -R16-O-R17-O- or a covalent bond; Q1 and Q2 are ind...  
WO/2014/190236A1
Embodiments in accordance with the present invention encompass water soluble poiyc-ycHc vinyl addition polymers having a norboraene type repeat unit derived from a norboraene type of monomer that encompasses a saccharide functional moiet...  
WO/2014/122407A3
A method for preparing a pyrazole of formula (I), characterised in that it involves reacting a sydnone of formula (II) with an alkyne of formula (III) in the presence of copper, in order to obtain a pyrazole compound of formula that is t...  
WO/2014/187365A1
The present invention relates to a oxabicyclo derivative, preparation method and use thereof, specifically to oxabicyclo derivatives shown by general formula (I) or hydrates, solvates, stereoisomers thereof, pharmaceutically acceptable s...  
WO/2014/187464A1
The present application discloses a synthetic mixture of oligosaccharides for treating a microbiota of a mammal, preferably a human, to reduce or eliminate the activity and/or the proportion of a microbe in the microbiota that is associa...  
WO/2014/183630A1
The present invention provides a compound as represented by formula I, which has a structure as follows: R1 and R2 are glycosyl, R3 is H, hydroxyl or methoxyl; R4 is hydroxyl or methoxyl; and R5 is H, hydroxyl or methoxyl. The present in...  
WO/2014/186027A1
Aryl or heteroaryl 1-substituted triazoles are prepared by cyclizing aryl or heteroaryl hydrazines with urea and alkyl orthoformates.  
WO/2014/178195A1
The present invention provides an immunity inducer and an immunity inducing method using same. The immunity inducer has an immunopotentiation effect on any target oligosaccharide antigen, in particular oligosaccharide antigens included i...  
WO/2014/140626A3
The present invention relates to a process for the preparation of polysaccharides of 8 or more monosaccharide residues in length and polysaccharides accessible by these processes, the process comprising coupling a chain extending polysac...  
WO/2014/145713A3
This disclosure relates generally to aminoglycoside derivatives of Formula (I) as described herein. The present disclosure also relates to pharmaceutical compositions containing these compounds and methods of treating bacterial infection...  
WO/2014/106826A3
The invention relates to purified compound of Formula 1. The invention includes all isomeric forms and tautomeric forms of the compound of Formula 1 and pharmaceutically acceptable salts and derivatives thereof. The present invention fur...  
WO/2014/173957A2
A compound of formula (I) wherein R is a C9-23 polyunsaturated alkenyl group; X is SO3R3, SO2R3, PO3R3, PO2R3, COCHal3, or COOR3; R1 and R2 are each independently H, a C1-6 a iky I group optionally substituted with OH, C6-10 aryl group o...  
WO/2014/167537A1
This invention relates to a chemo-enzymatic synthesis of oligosaccharidesof formula 1 wherein R is selected from -OH, -N3 and -OR6 wherein R6 is selected from allyl optionally substituted by one or more methyl, propargyl optionally subst...  
WO/2014/166139A1
The present invention relates to a method for synthesizing dibekacin and arbekacin. The method comprises: using kanamycin B as an initial raw material, protecting five amino groups of the kanamycin B by using t-butyloxycarboryl, protecti...  
WO/2014/165107A2
The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula (I) The invention also provides processes for making the compounds described herein. Furthermore, the ...  
WO/2014/159211A1
An alkenyl glycoside is prepared by reacting a metathesis-derived unsaturated fatty alcohol containing 10 to 30 carbon atoms with either (1 ) a reducible monosaccharide or composition hydrolyzable to a reducible monosaccharide, or (2) a ...  
WO/2014/157635A1
The purpose of the present invention is to provide a drug that demonstrates a pharmaceutical effect by having high mobility to the mid-brain and converting to bumetanide in the mid-brain, which is the primary site of epilepsy. The presen...  
WO/2014/154958A1
Process for preparing a composition (C1) represented by the formula (I): HO-CH2-(CHOH)n-CH2-O-(G)x-H, in which G represents the remainder of a reducing sugar, n is an integer equal to 2, 3 or 4 and x, which indicates the mean degree of p...  
WO/2014/148718A1
The present invention provides a spirostenol derivative, a composition for inducing a bone formation and/or promoting an osteoblast differentiation which includes the spirostenol derivative as an active ingredient, a biomaterial for indu...  
WO/2014/146875A1
The current invention is directed towards compounds of the general formula (I), wherein the integers are defined as follows: R1 is -(CH2)nCH(CH3)2, R2 is -(CH2)n+2CH(CH3)2, G1 selected from monosaccharides with 4 to 6 carbon atoms, x in ...  
WO/2014/146135A2
The present invention relates generally to steviol glycosides, as well as compositions comprising such steviol glycosides. The present invention further extends to methods of preparing and purifying such steviol glycosides and methods fo...  
WO/2014/140626A2
The present invention relates to a process for the preparation of polysaccharides of 8 or more monosaccharide residues in length and polysaccharides accessible by these processes, the process comprising coupling a chain extending polysac...  
WO/2014/133268A1
Disclosed are a method for preparing coumestrol and a method for preparing coumestrin preparation, wherein chitosan is treated for a predetermined amount of time during a bean growth period. Additionally, disclosed is the method for prep...  
WO/2014/086775A3
The present invention relates to binder compositions with improved amine components, and a method of manufacturing a collection of matter bound by said binder compositions.  
WO/2014/128660A1
The invention relates to methods for making an α-amino-aldehyde, preferably a 2-amino-2-deoxy sugar derivative, from an α-hydroxy-aldehyde, preferably an aldose. Intermediary 1-amino-1-deoxy-ketose derivatives, and their use as synthet...  
WO/2014/124245A1
The invention is directed to compositions and methods related to proteins that are physically associated with ceramide-like glycolipids for use as activators of NKT cells. The compositions and methods of the present invention are useful ...  

Matches 451 - 500 out of 13,177